CS Medica A/S announced that during Henriksen's absence, Gitte Henriksen and Heidi Ahlefeldt-Laurvig assumed co-CEO responsibilities, initiating a company-wide restructuring to secure faster revenue streams, mitigate supply risk, and stabilize cash flow--laying a strong foundation for 2025.